Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Transplantation|June 28, 2003
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysisJ I Roodnat, I C van Riemsdijk, P G H Mulder, et al.
Transplantation|December 10, 1999
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipientsP J Gregoor, R G de Sévaux, R J Hené, et al.
Breast Cancer Research and Treatment|April 17, 2023
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancerE T D Souwer, A Sanchez-Spitman, D J A R Moes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantationC C. Baan, A H. Balk, W M. Mol, et al.
Transplantation Proceedings|May 30, 2001
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapyN M van Besouw, B J van der Mast, P de Kuiper, et al.
Transplantation|August 5, 2000
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reducedN M van Besouw, B J van der Mast, P de Kuiper, et al.
BMC Infectious Diseases|January 19, 2020
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trialA Abdulla, T M J Ewoldt, N G M Hunfeld, et al.
Transplantation Proceedings|December 21, 2002
IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipientsC C Baan, A H M M Balk, A J van der Plas, et al.
Pediatric Blood & Cancer|February 17, 2017
Drug-drug interactions in pediatric oncology patientsT E Balk, I H van der Sijs, T van Gelder, et al.
European Journal of Clinical Pharmacology|July 7, 2017
Population pharmacokinetics of haloperidol in terminally ill adult patientsL G Franken, R A A Mathot, A D Masman, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Transplantation|June 28, 2003
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysisJ I Roodnat, I C van Riemsdijk, P G H Mulder, et al.
Transplantation|December 10, 1999
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipientsP J Gregoor, R G de Sévaux, R J Hené, et al.
Breast Cancer Research and Treatment|April 17, 2023
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancerE T D Souwer, A Sanchez-Spitman, D J A R Moes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Anti-CD25 therapy affects the death signals of activated T-cells after clinical heart transplantationC C. Baan, A H. Balk, W M. Mol, et al.
Transplantation Proceedings|May 30, 2001
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapyN M van Besouw, B J van der Mast, P de Kuiper, et al.
Transplantation|August 5, 2000
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reducedN M van Besouw, B J van der Mast, P de Kuiper, et al.
BMC Infectious Diseases|January 19, 2020
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trialA Abdulla, T M J Ewoldt, N G M Hunfeld, et al.
Transplantation Proceedings|December 21, 2002
IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipientsC C Baan, A H M M Balk, A J van der Plas, et al.
Pediatric Blood & Cancer|February 17, 2017
Drug-drug interactions in pediatric oncology patientsT E Balk, I H van der Sijs, T van Gelder, et al.
European Journal of Clinical Pharmacology|July 7, 2017
Population pharmacokinetics of haloperidol in terminally ill adult patientsL G Franken, R A A Mathot, A D Masman, et al.
Pageof 17